Holst Olsen, I. et al. 2012. First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: A single institution experience. Acta Oncologica. 51, 1 (Jan. 2012), 97–100. DOI:https://doi.org/10.3109/0284186X.2011.582881.